StockWatch
·
Biotechnology: Pharmaceutical Preparations
DelistingNov 18, 2026, 09:08 AM

MetaVia Inc. Faces Nasdaq Delisting Warning Over Equity Below $2.5M

AI Summary

MetaVia Inc. received a notice from Nasdaq indicating it no longer meets the minimum stockholders' equity requirement of $2.5 million for continued listing on The Nasdaq Capital Market. The company has 45 days to submit a plan to regain compliance, with a potential extension of up to 180 days if the plan is accepted. The notice does not immediately affect the trading of its common stock under the symbol MTVA.

Key Highlights

  • MetaVia Inc. no longer complies with Nasdaq's minimum stockholders' equity requirement of $2.5 million.
  • The company has until January 4, 2027, to submit a plan to regain compliance.
  • Nasdaq may grant an extension of up to 180 days to evidence compliance if the plan is accepted.
  • The notice has no immediate impact on the listing of MetaVia's common stock on The Nasdaq Capital Market.